FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3181574281> ?p ?o ?g. }

• W3181574281 endingPage "e607" @default.
• W3181574281 startingPage "e607" @default.
• W3181574281 abstract "Spinobulbar muscular atrophy (SBMA) is an X-linked adult-onset neuromuscular disorder that causes progressive weakness and androgen insensitivity in hemizygous males. This condition is reported to be extremely rare, but has higher prevalence in certain populations due to multiple founder effects. Anecdotal observations of a higher prevalence of SBMA in patients of Indigenous descent in Saskatchewan led us to perform this study, to estimate the disease prevalence, and to attempt to identify a founder effect.For our prevalence estimation, we identified patients with confirmed SBMA diagnosis from the Saskatoon neuromuscular clinic database for comparison with population data available from Statistics Canada. For our haplotype analysis, participants with SBMA were recruited from 2 neuromuscular clinics, as well as 5 control participants. Clinical data were collected, as well as a DNA sample using saliva kits. We performed targeted quantification of DXS1194, DXS1111, DXS135, and DXS1125 microsatellite repeats and the AR GGC repeat to attempt to identify a disease haplotype and compare it with prior studies.We estimate the prevalence of SBMA among persons of Indigenous descent in Saskatchewan as 14.7 per 100,000 population. Although we believe that this is an underestimate, this still appears to be the highest population prevalence for SBMA in the world. A total of 21 participants were recruited for the haplotype study, and we identified a unique haplotype that was shared among 13 participants with Indigenous ancestry. A second shared haplotype was identified in 2 participants, which may represent a second founder haplotype, but this would need to be confirmed with future studies.We describe a very high prevalence of SBMA in western Canadians of Indigenous descent, which appears to predominantly be due to a founder effect. This necessitates further studies of SBMA in these populations to comprehensively ascertain the disease prevalence and allow appropriate allocation of resources to support individuals living with this chronic disease." @default.
• W3181574281 created "2021-07-19" @default.
• W3181574281 creator A5043129865 @default.
• W3181574281 creator A5047600816 @default.
• W3181574281 creator A5051053936 @default.
• W3181574281 creator A5053623206 @default.
• W3181574281 creator A5054209263 @default.
• W3181574281 creator A5054502094 @default.
• W3181574281 creator A5069682579 @default.
• W3181574281 creator A5070667440 @default.
• W3181574281 creator A5082257259 @default.
• W3181574281 date "2021-07-08" @default.
• W3181574281 modified "2023-10-16" @default.
• W3181574281 title "Highly Elevated Prevalence of Spinobulbar Muscular Atrophy in Indigenous Communities in Canada Due to a Founder Effect" @default.
• W3181574281 cites W1985902870 @default.
• W3181574281 cites W1990194953 @default.
• W3181574281 cites W1997682022 @default.
• W3181574281 cites W2044688928 @default.
• W3181574281 cites W2046776107 @default.
• W3181574281 cites W2047040250 @default.
• W3181574281 cites W2054982708 @default.
• W3181574281 cites W2081447814 @default.
• W3181574281 cites W2082161743 @default.
• W3181574281 cites W2086027430 @default.
• W3181574281 cites W2105003307 @default.
• W3181574281 cites W2108834942 @default.
• W3181574281 cites W2110337205 @default.
• W3181574281 cites W2111714299 @default.
• W3181574281 cites W2113333419 @default.
• W3181574281 cites W2120567579 @default.
• W3181574281 cites W2147470069 @default.
• W3181574281 cites W2160030814 @default.
• W3181574281 cites W2161660950 @default.
• W3181574281 cites W2171803259 @default.
• W3181574281 cites W2765137020 @default.
• W3181574281 cites W2788178807 @default.
• W3181574281 cites W2884919921 @default.
• W3181574281 cites W2896598663 @default.
• W3181574281 cites W2934188750 @default.
• W3181574281 cites W2939925781 @default.
• W3181574281 cites W3015510664 @default.
• W3181574281 cites W3018690985 @default.
• W3181574281 cites W4242614327 @default.
• W3181574281 doi "https://doi.org/10.1212/nxg.0000000000000607" @default.
• W3181574281 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8267784" @default.
• W3181574281 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34250227" @default.
• W3181574281 hasPublicationYear "2021" @default.
• W3181574281 type Work @default.
• W3181574281 sameAs 3181574281 @default.
• W3181574281 citedByCount "3" @default.
• W3181574281 countsByYear W31815742812022 @default.
• W3181574281 countsByYear W31815742812023 @default.
• W3181574281 crossrefType "journal-article" @default.
• W3181574281 hasAuthorship W3181574281A5043129865 @default.
• W3181574281 hasAuthorship W3181574281A5047600816 @default.
• W3181574281 hasAuthorship W3181574281A5051053936 @default.
• W3181574281 hasAuthorship W3181574281A5053623206 @default.
• W3181574281 hasAuthorship W3181574281A5054209263 @default.
• W3181574281 hasAuthorship W3181574281A5054502094 @default.
• W3181574281 hasAuthorship W3181574281A5069682579 @default.
• W3181574281 hasAuthorship W3181574281A5070667440 @default.
• W3181574281 hasAuthorship W3181574281A5082257259 @default.
• W3181574281 hasBestOaLocation W31815742811 @default.
• W3181574281 hasConcept C104317684 @default.
• W3181574281 hasConcept C135763542 @default.
• W3181574281 hasConcept C144024400 @default.
• W3181574281 hasConcept C149923435 @default.
• W3181574281 hasConcept C180754005 @default.
• W3181574281 hasConcept C18903297 @default.
• W3181574281 hasConcept C195054827 @default.
• W3181574281 hasConcept C197754878 @default.
• W3181574281 hasConcept C2908647359 @default.
• W3181574281 hasConcept C54355233 @default.
• W3181574281 hasConcept C55958113 @default.
• W3181574281 hasConcept C61320498 @default.
• W3181574281 hasConcept C71924100 @default.
• W3181574281 hasConcept C86803240 @default.
• W3181574281 hasConcept C99454951 @default.
• W3181574281 hasConceptScore W3181574281C104317684 @default.
• W3181574281 hasConceptScore W3181574281C135763542 @default.
• W3181574281 hasConceptScore W3181574281C144024400 @default.
• W3181574281 hasConceptScore W3181574281C149923435 @default.
• W3181574281 hasConceptScore W3181574281C180754005 @default.
• W3181574281 hasConceptScore W3181574281C18903297 @default.
• W3181574281 hasConceptScore W3181574281C195054827 @default.
• W3181574281 hasConceptScore W3181574281C197754878 @default.
• W3181574281 hasConceptScore W3181574281C2908647359 @default.
• W3181574281 hasConceptScore W3181574281C54355233 @default.
• W3181574281 hasConceptScore W3181574281C55958113 @default.
• W3181574281 hasConceptScore W3181574281C61320498 @default.
• W3181574281 hasConceptScore W3181574281C71924100 @default.
• W3181574281 hasConceptScore W3181574281C86803240 @default.
• W3181574281 hasConceptScore W3181574281C99454951 @default.
• W3181574281 hasIssue "4" @default.
• W3181574281 hasLocation W31815742811 @default.
• W3181574281 hasLocation W31815742812 @default.
• W3181574281 hasLocation W31815742813 @default.
• W3181574281 hasOpenAccess W3181574281 @default.

• next